Telmisartan
- OralTelmisartanMicardis
Mechanism of Action
- Competitively inhibits the action of angiotensin II at AT1 receptors.
Clinical Use
Indications
- Hypertension - first line management, especially in patients with chronic kidney disease (CKD)
- Contraindications
- Severe renal impairment
- Severe hepatic impairment
- Patients on direct renin inhibitors (aliskiren)
- Adverse Effects
- Nausea / vomiting / diarrhoea
- Fatigue
- Oedema
- Upper respiratory tract infection